JP Patent

JP2019513145A — ５−メチル−１−フェニル−２−（１ｈ）−ピリドンの顆粒製剤及びその製造方法

Assigned to F Hoffmann La Roche AG · Expires 2019-05-23 · 7y expired

What this patent protects

本開示は、ピルフェニドンの顆粒製剤及びそのような製剤の製造方法に関する。

USPTO Abstract

本開示は、ピルフェニドンの顆粒製剤及びそのような製剤の製造方法に関する。

Drugs covered by this patent

Patent Metadata

Patent number: JP2019513145A
Jurisdiction: JP
Classification: —
Expires: 2019-05-23
Drug substance claim: No
Drug product claim: No
Assignee: F Hoffmann La Roche AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.